Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Reset all filters
01 2EGIS Pharmaceuticals PLC Budapest HU
02 1Moehs Iberica S.L. Rubi ES
03 2APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
04 1AREVIPHARMA GMBH Radebeul DE
05 1AUROBINDO PHARMA LIMITED Hyderabad IN
06 1CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
07 1CIPLA LIMITED Mumbai IN
08 1CTX LIFESCIENCES PVT. LIMITED Surat IN
09 1F Hoffmann-La Roche Ltd. Basel CH
10 1IPCA Laboratories Limited Mumbai IN
11 1KRKA, d.d., Novo mesto Novo mesto SI
12 1LUPIN LIMITED Mumbai IN
13 1QILU PHARMACEUTICAL CO., LTD. Jinan CN
14 1SHODHANA LABORATORIES PRIVATE LIMITED Hyderabad IN
15 1SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
16 1SYMED LABS LIMITED Hyderabad IN
17 1TAPI NL B.V. Amsterdam NL
18 1TIANISH LABORATORIES PRIVATE LIMITED Hyderabad IN
19 1URQUIMA S.A. Sant Fost De Campsentelles ES
20 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai CN
21 1ZYDUS LIFESCIENCES LIMITED Vadodara IN
Reset all filters
01 19Carvedilol
02 1Carvedilol, Micronised
03 1Carvedilol, Process-II, micronised
04 1Carvedilol, Site-II
05 1Carvedilol, Synthetic route B
Reset all filters
01 2China
02 1Germany
03 2Hungary
04 13India
05 1Slovenia
06 2Spain
07 1U.S.A
08 1Blank
Reset all filters
01 18Valid
02 5Withdrawn by Holder
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Certificate Number : R1-CEP 2016-314 - Rev 00
Status : Valid
Issue Date : 2023-08-28
Type : Chemical
Substance Number : 1745
Certificate Number : R1-CEP 2002-089 - Rev 03
Status : Valid
Issue Date : 2019-02-28
Type : Chemical
Substance Number : 1745
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Certificate Number : R1-CEP 2003-042 - Rev 03
Status : Valid
Issue Date : 2019-02-20
Type : Chemical
Substance Number : 1745
Carvedilol, Process-II, Micronised
Certificate Number : CEP 2024-534 - Rev 00
Status : Valid
Issue Date : 2025-02-28
Type : Chemical
Substance Number : 1745
Certificate Number : CEP 2014-201 - Rev 02
Status : Valid
Issue Date : 2025-01-20
Type : Chemical
Substance Number : 1745
Certificate Number : R1-CEP 2002-001 - Rev 03
Status : Valid
Issue Date : 2012-07-25
Type : Chemical
Substance Number : 1745
Certificate Number : R1-CEP 2007-298 - Rev 01
Status : Valid
Issue Date : 2019-06-25
Type : Chemical
Substance Number : 1745
Certificate Number : R1-CEP 2008-259 - Rev 01
Status : Valid
Issue Date : 2022-07-28
Type : Chemical
Substance Number : 1745
Certificate Number : R1-CEP 2004-230 - Rev 05
Status : Valid
Issue Date : 2015-07-28
Type : Chemical
Substance Number : 1745
Certificate Number : R1-CEP 2004-287 - Rev 05
Status : Valid
Issue Date : 2021-07-01
Type : Chemical
Substance Number : 1745
80
PharmaCompass offers a list of Carvedilol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carvedilol manufacturer or Carvedilol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carvedilol manufacturer or Carvedilol supplier.
PharmaCompass also assists you with knowing the Carvedilol API Price utilized in the formulation of products. Carvedilol API Price is not always fixed or binding as the Carvedilol Price is obtained through a variety of data sources. The Carvedilol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A GlaxoSmithKline brand of carvedilol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GlaxoSmithKline brand of carvedilol, including repackagers and relabelers. The FDA regulates GlaxoSmithKline brand of carvedilol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GlaxoSmithKline brand of carvedilol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of GlaxoSmithKline brand of carvedilol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A GlaxoSmithKline brand of carvedilol supplier is an individual or a company that provides GlaxoSmithKline brand of carvedilol active pharmaceutical ingredient (API) or GlaxoSmithKline brand of carvedilol finished formulations upon request. The GlaxoSmithKline brand of carvedilol suppliers may include GlaxoSmithKline brand of carvedilol API manufacturers, exporters, distributors and traders.
click here to find a list of GlaxoSmithKline brand of carvedilol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A GlaxoSmithKline brand of carvedilol CEP of the European Pharmacopoeia monograph is often referred to as a GlaxoSmithKline brand of carvedilol Certificate of Suitability (COS). The purpose of a GlaxoSmithKline brand of carvedilol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of GlaxoSmithKline brand of carvedilol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of GlaxoSmithKline brand of carvedilol to their clients by showing that a GlaxoSmithKline brand of carvedilol CEP has been issued for it. The manufacturer submits a GlaxoSmithKline brand of carvedilol CEP (COS) as part of the market authorization procedure, and it takes on the role of a GlaxoSmithKline brand of carvedilol CEP holder for the record. Additionally, the data presented in the GlaxoSmithKline brand of carvedilol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the GlaxoSmithKline brand of carvedilol DMF.
A GlaxoSmithKline brand of carvedilol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. GlaxoSmithKline brand of carvedilol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of GlaxoSmithKline brand of carvedilol suppliers with CEP (COS) on PharmaCompass.
We have 19 companies offering GlaxoSmithKline brand of carvedilol
Get in contact with the supplier of your choice: